{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:05:44Z","timestamp":1776413144733,"version":"3.51.2"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ejphar.2010.05.048","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T04:44:56Z","timestamp":1276145096000},"page":"107-112","source":"Crossref","is-referenced-by-count":20,"title":["Aldosterone receptor blockade inhibits degenerative processes in the early stage of calcific aortic stenosis"],"prefix":"10.1016","volume":"642","author":[{"given":"Spyridon","family":"Gkizas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Koumoundourou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xara","family":"Sirinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stamatina","family":"Rokidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimosthenis","family":"Mavrilas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petros","family":"Koutsoukos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Papalois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Apostolakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2010.05.048_bib1","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jacc.2006.11.043","article-title":"Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits","volume":"49","author":"Arishiro","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib2","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCULATIONAHA.109.900027","article-title":"Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial","volume":"121","author":"Chan","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib3","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.162.20.2345","article-title":"The risk of the development of aortic stenosis in patients with \"benign\" aortic valve thickening","volume":"162","author":"Cosmi","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ejphar.2010.05.048_bib4","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMoa043876","article-title":"A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis","volume":"352","author":"Cowell","year":"2005","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ejphar.2010.05.048_bib5","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0735-1097(03)00090-1","article-title":"Experimental aortic valve stenosis in rabbits","volume":"41","author":"Drolet","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib6","first-page":"381","article-title":"Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium","volume":"17","author":"Drolet","year":"2008","journal-title":"J. Heart Valve Dis."},{"key":"10.1016\/j.ejphar.2010.05.048_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9149(02)03011-4","article-title":"Progression of aortic valve sclerosis to aortic stenosis","volume":"91","author":"Faggiano","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib8","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1161\/CIRCULATIONAHA.104.486738","article-title":"Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies","volume":"111","author":"Freeman","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib9","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1161\/CIRCULATIONAHA.108.809194","volume":"119","author":"Iraqi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/ncpendmet0676","article-title":"Drug Insight: eplerenone, a mineralocorticoid-receptor antagonist","volume":"4","author":"McManus","year":"2008","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2010.05.048_bib11","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/01.CIR.103.11.1522","article-title":"Bone formation and inflammation in cardiac valves","volume":"103","author":"Mohler","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib12","first-page":"366","article-title":"Low-dose Eplerenone Down-regulates Caveolin-1 and Improves Endothelial Function by Mechanisms Independent of MR Antagonism","volume":"118","author":"Mutoh","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib13","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1161\/01.CIR.0000035655.45453.D2","article-title":"Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma","volume":"106","author":"O'Brien","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib14","series-title":"Braunwald's Heart Disease","first-page":"1625","article-title":"Calcific Aortic Stenosis","author":"Otto","year":"2008"},{"key":"10.1016\/j.ejphar.2010.05.048_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0002-9149(02)03010-2","article-title":"Relation between cardiovascular risk factors and nonrheumatic severe calcific aortic stenosis among patients with a three-cuspid aortic valve","volume":"91","author":"Peltier","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib16","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1161\/01.CIR.0000015854.60710.10","article-title":"Mineralocorticoid receptor antagonism in experimental atherosclerosis","volume":"105","author":"Rajagopalan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib17","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.0000017435.87463.72","article-title":"Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve","volume":"105","author":"Rajamannan","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/heart.89.7.801","article-title":"Calcific aortic stenosis: From bench to bedside\u2014emerging clinical and cellular concepts","volume":"89","author":"Rajamannan","year":"2003","journal-title":"Heart"},{"key":"10.1016\/j.ejphar.2010.05.048_bib19","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.0000070591.21548.69","article-title":"Human aortic valve calcification is associated with an osteoblast phenotype","volume":"107","author":"Rajamannan","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2010.05.048_bib20","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rossebo","year":"2008","journal-title":"N Engl J. Med."},{"key":"10.1016\/j.ejphar.2010.05.048_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0735-1097(96)00563-3","article-title":"Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study","volume":"29","author":"Stewart","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ahj.2008.03.012","article-title":"A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis","volume":"156","author":"Stewart","year":"2008","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ejphar.2010.05.048_bib23","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/clc.20324","article-title":"A comparison of the aldosterone-blocking agents eplerenone and spironolactone","volume":"31","author":"Struthers","year":"2008","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ejphar.2010.05.048_bib24","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/00313029700169315","article-title":"Calcification of the aortic valve: its progression and grading","volume":"29","author":"Warren","year":"1997","journal-title":"Pathology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910004991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299910004991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T08:20:17Z","timestamp":1544430017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299910004991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":24,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0014299910004991"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2010.05.048","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}